Clonazepam Recall 2025 Calendar

Clonazepam Recall 2025 Calendar. Product Recalls In 2025 By Fda List Sam Newman would expand an existing recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) over concerns that the packaging had been mislabeled with the incorrect dosing. (FDA) recently announced that Endo USA, Inc., a Pennsylvania-based company, had recalled 113,331 packages of clonazepam medication

Clonazepam is a benzodiazepine used to treat panic. • On November , O Q, Endo announced a voluntary, consumer level recall of many lots of clonazepam ODT tablets because of potential product carton strength mislabeling

F.D.A. Some Clonazepam Recalled Over Incorrect Doses on Labels The New York Times

The expanded recall involves Clonazepam Orally Disintegrating Tablets, with strength in USP 0.125 mg, 0.25 mg, 1 mg, and 2mg, packaged in cartons containing 60 tablets packed into 10 blister strips each containing 6 tablets, with various lot codes and National Drug Code or NDC. The FDA released the details of the recall in a statement on Nov would expand an existing recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) over concerns that the packaging had been mislabeled with the incorrect dosing.

Clonazepam (โคลนาซีแพม) สรรพคุณ ข้อบ่งใช้ ผลข้างเคียง. The Pennsylvania-based company Endo, Inc., issued a voluntary nationwide recall for Clonazepam Orally Disintegrating Tablets because "a limited number of cartons" were printed with the incorrect. (OTCQX: NDOI) ("Endo") announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of Clonazepam Orally.

Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (CIV) Due to. • On November , O Q, Endo announced a voluntary, consumer level recall of many lots of clonazepam ODT tablets because of potential product carton strength mislabeling However, the blister strips and tablets inside the product pack reflect the correct strength for the lot.